Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?

Journal of Pain and Symptom Management

Volumn 43, Issue 3, 2012, Pages 614-624

  Johnson, Miriam J ^a   Abernethy, Amy P ^b,c   Currow, David C ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

dyspnea; opioid; Palliative care; research

Indexed keywords

DIAMORPHINE; DIHYDROCODEINE; ENDORPHIN; HYDROMORPHONE; MIDAZOLAM; MORPHINE; NALOXONE; OPIATE; OPIATE RECEPTOR; OXYCODONE; PLACEBO;

ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONSTIPATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NONHUMAN; PRESCRIPTION;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; DRUG RESISTANCE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; DYSPNEA; EVIDENCE-BASED MEDICINE; HUMANS; INFUSIONS, PARENTERAL; PALLIATIVE CARE; RECEPTORS, OPIOID, MU;

EID: 84863417588     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.04.024     Document Type: Article

References (69)

1. M. Gysels, and I.J. Higginson Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness J Pain Symptom Manage 36 2008 451 460
2. E. Grant, S.A. Murray, and M. Kendall Spiritual issues and needs: perspectives from patients with advanced cancer and nonmalignant disease. A qualitative study Palliat Support Care 2 2004 371 378
3. S.A. Murray, K. Boyd, and M. Kendall Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community BMJ 325 2002 929
4. A.E. Rogers, J.M. Addington-Hall, and A.J. Abery Knowledge and communication difficulties for patients with chronic heart failure: qualitative study BMJ 321 2000 605 607
5. H. Anderson, C. Ward, and A. Eardley The concerns of patients under palliative care and a heart failure clinic are not being met Palliat Med 15 2001 279 286 (Pubitemid 32640546)
6. J.P. Solano, B. Gomes, and I.J. Higginson A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease J Pain Symptom Manage 31 2006 58 69 (Pubitemid 43143299)
7. P. Edmonds, S. Karlsen, S. Khan, and J. Addington-Hall A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer Palliat Med 15 2001 287 295 (Pubitemid 32640547)
8. C. Bausewein, S. Booth, and M. Gysels Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer J Palliat Med 13 2010 1109 1118
9. J.M. Gore, C.J. Brophy, and M.A. Greenstone How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer Thorax 55 2000 1000 1006
10. A.P. Abernethy, and J.L. Wheeler Total dyspnoea Curr Opin Support Palliat Care 2 2008 110 113
11. A. von Leupoldt, T. Sommer, and S. Kegat Dyspnea and pain share emotion-related brain network Neuroimage 48 2009 200 206
12. Masso M, Dodds S, Fildes D, Yeatman H, Eagar K. Ethical research in palliative care: a guide through the Human Research Ethics Committee process. Centre for Health Development-CHSD 2004. Available from http://ro.uow.edu.au/ cgi/viewcontent.cgi?article=1011&context=chsd. Accessed December 3, 2011.
13. A.P. Abernethy, L.C. Hanson, D.S. Main, and J.S. Kutner Palliative care clinical research networks, a requirement for evidence-based palliative care: time for coordinated action J Palliat Med 10 2007 845 850 (Pubitemid 47511982)
14. A.P. Abernethy, N.M. Aziz, and E. Basch A strategy to advance the evidence base in palliative medicine: formation of a Palliative Care Research Cooperative Group J Palliat Med 13 2010 1407 1413
15. T.J. Smith, P. Coyne, W. French, V. Ramakrishnan, and P. Corrigan Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned J Palliat Med 12 2009 771 772
16. D.C. Currow Why don't we do more rigorous clinical research so that we can stop experimenting on patients? J Palliat Med 13 2010 636 637
17. A.L. Jennings, A.N. Davies, J.P. Higgins, J.S. Gibbs, and K.E. Broadley A systematic review of the use of opioids in the management of dyspnoea Thorax 57 2002 939 944 (Pubitemid 35316271)
18. A.P. Abernethy, D.C. Currow, and P. Frith Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
19. M.J. Johnson, T.A. McDonagh, A. Harkness, S.E. McKay, and H.J. Dargie Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study Eur J Heart Fail 4 2002 753 756 (Pubitemid 35403084)
20. D.C. Currow, C. McDonald, and S. Oaten Once daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study J Pain Symptom Manage 42 2011 388 399
21. Anonymous Improving research methodology in breathlessness: a meeting convened by the MRC clinical trials unit and the Cicely Saunders Foundation Palliat Med 20 2006 219 220
22. A.L. Ries Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale COPD 2 2005 105 110 (Pubitemid 40776230)
23. D.A. Mahler, J.A. Murray, and L.A. Waterman Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD Eur Respir J 33 2009 771 777
24. K.T. Pattinson, R.J. Governo, and B.J. MacIntosh Opioids depress cortical centers responsible for the volitional control of respiration J Neurosci 29 2009 8177 8186
25. D.C. Currow, J. Plummer, P. Frith, and A.P. Abernethy Can we predict which patients with refractory dyspnea will respond to opioids? J Palliat Med 10 2007 1031 1036 (Pubitemid 350073568)
26. I. Ben-Aharon, A. Gafter-Gvili, M. Paul, L. Leibovici, and S.M. Stemmer Interventions for alleviating cancer-related dyspnea: a systematic review J Clin Oncol 26 2008 2396 2404
27. S. Booth, S.H. Moosavi, and I.J. Higginson The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy Nat Clin Pract Oncol 5 2008 90 100 (Pubitemid 351188930)
28. R. Viola, C. Kiteley, N.S. Lloyd, J.A. Mackay, J. Wilson, and R.K. Wong The management of dyspnea in cancer patients: a systematic review Support Care Cancer 16 2008 329 337
29. M.A. Charles, L. Reymond, and F. Israel Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline J Pain Symptom Manage 36 2008 29 38
30. P.J. Coyne, R. Viswanathan, and T.J. Smith Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea J Pain Symptom Manage 23 2002 157 160 (Pubitemid 34158649)
31. G.R. Graff, J.M. Stark, and R. Grueber Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient Respiration 71 2004 646 649 (Pubitemid 40091441)
32. W. Beauford, T.T. Saylor, D.W. Stansbury, K. Avalos, and R.W. Light Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient Chest 104 1993 175 178 (Pubitemid 23204553)
33. A.R. Masood, J.W. Reed, and S.H. Thomas Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease Thorax 50 1995 629 634
34. A.A. Gauna, S.K. Kang, M.L. Triano, E.R. Swatko, and V.J. Vanston Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series J Palliat Med 11 2008 643 648 (Pubitemid 351630193)
35. T. Sitte, and C. Bausewein Intranasal fentanyl for episodic breathlessness J Pain Symptom Manage 36 2008 e3 e6
36. M.A. Benitez-Rosario, A.S. Martin, and M. Feria Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients J Pain Symptom Manage 30 2005 395 397 (Pubitemid 41718958)
37. M.W. Lipsey, and D.B. Wilson The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis Am Psychol 48 1993 1181 1209
38. D.S. Ander, I.P. Aisiku, J.J. Ratcliff, K.H. Todd, and K. Gotsch Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 10 2004 188 191
39. D.J. Karras, M.E. Sammon, and C.A. Terregino Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334 (Pubitemid 30207971)
40. F. Fontana, P. Bernardi, and E.M. Pich Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure Eur Heart J 14 1993 219 225 (Pubitemid 23089508)
41. G.S. Francis Neuroendocrine activity in congestive heart failure Am J Cardiol 66 1990 33D 38D
42. G.P. Perna, S. Modoni, G. Valle, M. Stanislao, and F. Loperfido Plasma beta-endorphin response to exercise in patients with congestive heart failure Chest 111 1997 19 22 (Pubitemid 27043601)
43. S. Pepe, O.W. van den Brink, E.G. Lakatta, and R.P. Xiao Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart Cardiovasc Res 63 2004 414 422 (Pubitemid 38970185)
44. T.M. Wong, and J. Shan Modulation of sympathetic actions on the heart by opioid receptor stimulation J Biomed Sci 8 2001 299 306 (Pubitemid 32678935)
45. T.P. Chua, D. Harrington, and P. Ponikowski Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure J Am Coll Cardiol 29 1997 147 152 (Pubitemid 27028732)
46. C. Peiffer Dyspnea and emotion: what can we learn from functional brain imaging? Am J Respir Crit Care Med 177 2008 937 939 (Pubitemid 351717584)
47. A. von Leupoldt, and B. Dahme Cortical substrates for the perception of dyspnea Chest 128 2005 345 354 (Pubitemid 40994494)
48. A. von Leupoldt, T. Sommer, and S. Kegat The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala Am J Respir Crit Care Med 177 2008 1026 1032 (Pubitemid 351717598)
49. A. von Leupoldt, T. Sommer, and S. Kegat Down-regulation of insular cortex responses to dyspnea and pain in asthma Am J Respir Crit Care Med 180 2009 232 238
50. A. von Leupoldt, P.Y. Chan, M.M. Bradley, P.J. Lang, and P.W. Davenport The impact of anxiety on the neural processing of respiratory sensations Neuroimage 55 2011 247 252
51. S.G. Oxberry, D. Torgerson, A.L. Clark, J.G.F. Cleland, and M.J. Johnson Opioids for dyspnoea in chronic heart failure Eur J Heart Fail 13 2011 1006 1012
52. R. Horton, G. Rocker, and D. Currow The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease? Curr Opin Support Palliat Care 4 2010 92 96
53. D.C. Currow, and C. Davis How quick are palliative care doctors to adopt new evidence Eur J Palliat Care 17 2010 5
54. A.H. Navigante, L.C. Cerchietti, M.A. Castro, M.A. Lutteral, and M.E. Cabalar Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer J Pain Symptom Manage 31 2006 38 47 (Pubitemid 43143297)
55. R.W. Light, D.W. Stansbury, and J.S. Webster Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD Chest 109 1996 975 981 (Pubitemid 26113640)
56. Rocker GM, Young J, Horton R. Using opioids to treat dyspnea in advanced COPD: a survey of Canadian clinicians. 2008. [abstract]. Available from http://meeting.chestpubs.org/cgi/content/abstract/134/4/s29001. Accessed December 3, 2011.
57. J. Young, C. Simpson, M. Farquhar, and G. Rocker Attitudes to using opioids to treat dyspnea in advanced COPD: a qualitative study of family physicians and respiratory therapists [abstract] Chest Meeting Abstr 136 2009 91S
58. M. Gott, C. Gardiner, and N. Small The effect of the Shipman murders on clinician attitudes to prescribing opiates for dyspnoea in end-stage chronic obstructive pulmonary disease in England Prog Palliat Care 18 2010 79 84
59. S.G. Oxberry, and M.J. Johnson Attitudes to morphine in chronic heart failure patients BMJ Supportive and Palliative Care 2011 [In Press]
60. A.P. Abernethy, C.F. McDonald, and P.A. Frith Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial Lancet 376 2010 784 793
61. R. Barton, A. English, S. Nabb, A.S. Rigby, and M.J. Johnson A randomised trial of high vs. low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study Lung Cancer 70 2010 313 319
62. S. Booth, M. Farquhar, M. Gysels, C. Bausewein, and I.J. Higginson The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study Palliat Support Care 4 2006 287 293
63. S. Booth, S. Silvester, and C. Todd Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers Palliat Support Care 1 2003 337 344
64. C. Bausewein, M. Farquhar, S. Booth, M. Gysels, and I.J. Higginson Measurement of breathlessness in advanced disease: a systematic review Respir Med 101 2007 399 410 (Pubitemid 46205909)
65. S. Dorman, A. Byrne, and A. Edwards Which measurement scales should we use to measure breathlessness in palliative care? A systematic review Palliat Med 21 2007 177 191 (Pubitemid 46958244)
66. S. Dorman, C. Jolley, and A. Abernethy Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup Palliat Med 23 2009 213 227
67. M.J. Johnson, S.G. Oxberry, J.G. Cleland, and A.L. Clark Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review Eur J Heart Fail 12 2010 137 147
68. NHS Centre for Reviews and Dissemination Getting evidence into practice Effective Health Care 5 1999 1 16
69. D.C. Currow, M.R. Agar, and A.P. Abernethy Tackling the challenges of clinical trials in palliative care Pharm Med 25 2011 7 15